Optimizing Treatment of Patients on LDL-C–Lowering Therapies

Optimizing LDL-C Management in Clinical Practice

Strategies for Ensuring Optimal LDL-C–Lowering Therapy

Systematic monitoring: Implement regular lipid panel follow-ups and automated reminders in electronic medical record systems to identify patients not meeting LDL-C target levels

Risk stratification: Prioritize therapy intensification based on atherosclerotic cardiovascular disease (ASCVD) risk factors and comorbidities to focus on high-risk patients requiring more aggressive intervention

Algorithm-based approaches: Develop clear clinical pathways and decision trees for therapy escalation that can be implemented by the entire health care team

Team-based care models: Utilize pharmacists, nurse practitioners, and care coordinators for medication reconciliation, adherence monitoring, and protocol-driven therapy adjustments

Facilitating Therapy Intensification Through Collaboration

• Delegation protocols: Establish collaborative practice agreements allowing qualified team members to adjust medications per defined protocols without requiring physician visits
• Cross-disciplinary education: Ensure all team members understand current lipid guidelines and therapy options to provide consistent messaging
• Patient engagement systems: Implement proactive outreach to patients with suboptimal LDL-C level control to discuss therapy intensification
• Care transitions management: Develop structured handoffs between inpatient and outpatient settings to maintain continuity of lipid management

Essential Components for Shared Decision-Making Tools

• Personalized risk visualization: Interactive tools showing individual ASCVD risk reduction with various therapy intensification options
• Adverse effect profiles: Clear comparisons of potential adverse effects between treatment options with absolute risk data
• Cost considerations: Transparent information about medication costs, insurance coverage, and available assistance programs
• Treatment burden assessment: Tools to evaluate the impact of additional medications on quality of life and daily routines
• Value clarification exercises: Methods to help patients prioritize their health goals and concerns about additional therapies

Cultural adaptations: Decision aids that address cultural beliefs and preferences about medication use and cardiovascular risk management